157 related articles for article (PubMed ID: 9702926)
1. Regression of LVH or improved prognosis (or both): what is the question?
Lip GY; Lydakis C; Zarifis J; Messerli FH
J Hum Hypertens; 1998 Jul; 12(7):423-5. PubMed ID: 9702926
[No Abstract] [Full Text] [Related]
2. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
Clement DL; De Buyzere M; Duprez D
Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
[TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular hypertrophy in hypertension--does it reduce cardiovascular risk?
Braz Nogueira J
Rev Port Cardiol; 2005; 24(7-8):1007-13. PubMed ID: 16240686
[TBL] [Abstract][Full Text] [Related]
4. Clinical methods for the detection and management of left ventricular hypertrophy.
Swamy RS; Lang RM
Indian Heart J; 2010; 62(5):384-7. PubMed ID: 23189877
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Antihypertensive Drugs on Regression of Left Ventricular Hypertrophy].
Koziolova NA; Shatunova IM
Kardiologiia; 2015; 55(6):88-97. PubMed ID: 26625525
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy.
Mizuno R; Fujimoto S; Saito Y; Yamazaki M
Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069
[TBL] [Abstract][Full Text] [Related]
7. Hypertensive heart disease.
Diamond JA; Phillips RA
Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
[TBL] [Abstract][Full Text] [Related]
8. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
Borzova NV; Gorbachenkov AA
Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
10. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
Pierdomenico SD; Lapenna D; Cuccurullo F
Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive Therapies and Left Ventricular Hypertrophy.
Soliman EZ; Prineas RJ
Curr Hypertens Rep; 2017 Sep; 19(10):79. PubMed ID: 28929454
[TBL] [Abstract][Full Text] [Related]
12. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
13. [A decrease in left ventricular hypertrophy and the dynamics of the parameters of circadian BP monitoring under the influence of ramipril in patients with essential arterial hypertension].
Pekarskiĭ SE; Vorozhtsova IN; Mordovin VF
Ter Arkh; 1997; 69(4):18-20. PubMed ID: 9213948
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
Dahlöf B
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
[TBL] [Abstract][Full Text] [Related]
15. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
16. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy is a key goal of hypertension management.
Zhang R; Crump J; Reisin E
Curr Hypertens Rep; 2003 Aug; 5(4):301-8. PubMed ID: 12844464
[TBL] [Abstract][Full Text] [Related]
18. [The hypertensive heart (cardiac hypertension) and secondary drug prophylaxis].
Metelitsa VI
Ter Arkh; 1992; 64(9):112-6. PubMed ID: 1481146
[No Abstract] [Full Text] [Related]
19. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.
Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A
Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219
[TBL] [Abstract][Full Text] [Related]
20. Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy.
Hansson L
Adv Exp Med Biol; 1997; 432():189-90. PubMed ID: 9433525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
